IMCR
Immunocore Holdings plc
NASDAQ · Healthcare · Biotechnology · GB
$36.13
−3.83%Leverage
- Debt / equity
- 1.04x
- Net debt / equity
- -0.12x
- Debt / assets
- 0.39x
- Debt / EBITDA
- 26.83x
- Net debt / EBITDA
- -3.08x
Liquidity & coverage
- Current ratio
- 4.47x
- Quick ratio
- 4.44x
- Cash ratio
- 3.74x
- Interest coverage
- -1.52x
- EBITDA / interest
- 1.41x
- Working capital
- $815.8M
Cash & dividend
- FCF / debt
- -0.14x
- Cash flow / debt
- -0.13x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026